Details for New Drug Application (NDA): 021567
✉ Email this page to a colleague
The generic ingredient in REYATAZ is atazanavir sulfate. There are twenty-five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the atazanavir sulfate profile page.
Summary for 021567
Tradename: | REYATAZ |
Applicant: | Bristol Myers Squibb |
Ingredient: | atazanavir sulfate |
Patents: | 0 |
Suppliers and Packaging for NDA: 021567
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
REYATAZ | atazanavir sulfate | CAPSULE;ORAL | 021567 | NDA | E.R. Squibb & Sons, L.L.C. | 0003-3622 | 0003-3622-12 | 30 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0003-3622-12) |
REYATAZ | atazanavir sulfate | CAPSULE;ORAL | 021567 | NDA | E.R. Squibb & Sons, L.L.C. | 0003-3631 | 0003-3631-12 | 60 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0003-3631-12) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jun 20, 2003 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jun 20, 2003 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 200MG BASE | ||||
Approval Date: | Jun 20, 2003 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021567
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | REYATAZ | atazanavir sulfate | CAPSULE;ORAL | 021567-001 | Jun 20, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | REYATAZ | atazanavir sulfate | CAPSULE;ORAL | 021567-002 | Jun 20, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | REYATAZ | atazanavir sulfate | CAPSULE;ORAL | 021567-003 | Jun 20, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | REYATAZ | atazanavir sulfate | CAPSULE;ORAL | 021567-004 | Oct 16, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | REYATAZ | atazanavir sulfate | CAPSULE;ORAL | 021567-004 | Oct 16, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | REYATAZ | atazanavir sulfate | CAPSULE;ORAL | 021567-003 | Jun 20, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Bristol Myers Squibb | REYATAZ | atazanavir sulfate | CAPSULE;ORAL | 021567-002 | Jun 20, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription